MUC1 and cancer: Our observations elicit that occupation states and glycoforms in the five potential O-glycosylation sites in MUC1 TRD24,34 strongly influence the inhibitory effect by anti-MUC1 mAbs on the anti-cancer activity through interaction with key partner molecules.